Literature DB >> 15250837

Maspin expression in normal and neoplastic salivary gland.

Ricardo de Lima Navarro1, Marília Trierveiler Martins, Vera Cavalcanti de Araújo.   

Abstract

BACKGROUND: Maspin inhibits cell motility, invasion and metastasis. Loss or reduction in maspin expression has been associated with tumoral progression.
METHODS: The presence of maspin was studied immunohistochemically in salivary gland tumours presenting cells with myoepithelial differentiation in their composition, and in normal salivary gland.
RESULTS: Pleomorphic adenoma (PA) presented high expression of maspin, except in the spindle cells and occasional luminal cells. Epithelial-myoepithelial carcinoma and tubular adenoid cystic carcinoma (ACC) showed intense expression in all cells. Cribriform ACC evidenced only few positive cells of the luminal type, while solid subtype showed rare positive cells. Normal salivary gland tissue has shown low levels of maspin positivity.
CONCLUSIONS: Maspin has small participation in normal salivary gland, is increased in PA, and decreases as the histological malignancy raises. Hence, in salivary gland, its expression is not exclusive of myoepithelial cells; thus, it should not be used as a marker for this cell. Nevertheless, we believe it is an important marker of biological behaviour in these tumours.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15250837     DOI: 10.1111/j.1600-0714.2004.00220.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  8 in total

Review 1.  Myoepithelial Cells (MEC) of the Salivary Glands in Health and Tumours.

Authors:  Ravi Teja Chitturi; V Veeravarmal; R Madhavan Nirmal; B Venkat Ramana Reddy
Journal:  J Clin Diagn Res       Date:  2015-03-01

2.  Maspin expression in carcinoma ex pleomorphic adenoma.

Authors:  M T Martins; A Altemani; L Freitas; V C Araújo
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

3.  Loss of heterozygosity occurs predominantly, but not exclusively, in the epithelial compartment of pleomorphic adenoma.

Authors:  Micaela Poetsch; Anett Zimmermann; Eduard Wolf; Britta Kleist
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

Review 4.  Maspin as a tumour suppressor in salivary gland tumour.

Authors:  Bassel Tarakji; Nipun Ashok; Mohammad Kinan Sheirawan; Mohammed Alsakran Altamimi; Faris Alenzi; Saleh Nasser Azzeghaiby; Kusai Baroudi; Mohammad Zakaria Nassani
Journal:  J Clin Diagn Res       Date:  2014-12-05

5.  Maspin expression in gastrointestinal stromal tumors.

Authors:  Saduman Balaban Adim; Gulaydan Filiz; Ozkan Kanat; Omer Yerci; Halil Ozguc; Berna Aytac
Journal:  World J Surg Oncol       Date:  2010-03-26       Impact factor: 2.754

6.  Maspin and MCM2 immunoprofiling in salivary gland carcinomas.

Authors:  Shaimaa E Ghazy; Iman M Helmy; Houry M Baghdadi
Journal:  Diagn Pathol       Date:  2011-09-26       Impact factor: 2.644

7.  Comparative Analysis of P63, Maspin and Matrix Metalloproteinase 2 Expression in Mucoepidermoid Carcinoma and Adenoid Cystic Carcinoma of Salivary Glands.

Authors:  Nasim Taghavi; Farzad Yazdani; Alireza Akbarzadeh Baghban; Soudabeh Sargolzaei; Parisa Kardouni Khoozestani
Journal:  J Dent (Shiraz)       Date:  2020-06

8.  Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice.

Authors:  Toshitaka Nagao; Eiichi Sato; Rie Inoue; Hisashi Oshiro; Reisuke H Takahashi; Takeshi Nagai; Maki Yoshida; Fumie Suzuki; Hiyo Obikane; Mitsumasa Yamashina; Jun Matsubayashi
Journal:  Acta Histochem Cytochem       Date:  2012-09-22       Impact factor: 1.938

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.